Author Correction: Mobilization strategies with and without plerixafor for autologous stem cell transplant in patients with multiple myeloma (Bone Marrow Transplantation, (2024), 59, 10, (1440-1448), 10.1038/s41409-024-02385-1)

Zachary M. Avigan; Suzanne Arinsburg; Darren Pan; Tomer Mark; Christopher Fausel; Joseph Bubalo; Gary Milkovich; Erin Moshier; Weijia Fu; Ajai Chari; Joshua Richter

doi:10.1038/s41409-024-02442-9

Author Correction: Mobilization strategies with and without plerixafor for autologous stem cell transplant in patients with multiple myeloma (Bone Marrow Transplantation, (2024), 59, 10, (1440-1448), 10.1038/s41409-024-02385-1)

Zachary M. Avigan
, Suzanne Arinsburg
, Darren Pan
, Tomer Mark
, Christopher Fausel
, Joseph Bubalo
, Gary Milkovich
, Erin Moshier
, Weijia Fu
, Ajai Chari
, Joshua Richter

Research output: Contribution to journal › Comment/debate

Abstract

Correction to: Bone Marrow Transplantationhttps://doi.org/10.1038/s41409-024-02385-1, published online 31 July 2024 Following the publication of this article it was noted that two authors were omitted: Erin Moshier¹ and Weijia Fu¹¹Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA. These authors have now been added to the author list. The Competing Interests statement has been updated as follows: DP: honoraria from Sanofi. TM: Employment at Karyopharm Therapeutics. AC: consulting for Sanofi. JR: consulting and honoraria from Sanofi. ZMA, SA, CF, JB, EM, WF and GM have no relevant conflicts of interest to disclose. The original article has been corrected.

Original language	English
Pages (from-to)	115
Number of pages	1
Journal	Bone Marrow Transplantation
Volume	60
Issue number	1
DOIs	https://doi.org/10.1038/s41409-024-02442-9
State	Published - Jan 2025

Access to Document

10.1038/s41409-024-02442-9

Fingerprint

Dive into the research topics of 'Author Correction: Mobilization strategies with and without plerixafor for autologous stem cell transplant in patients with multiple myeloma (Bone Marrow Transplantation, (2024), 59, 10, (1440-1448), 10.1038/s41409-024-02385-1)'. Together they form a unique fingerprint.

Cite this

Avigan, Z. M., Arinsburg, S., Pan, D., Mark, T., Fausel, C., Bubalo, J., Milkovich, G., Moshier, E., Fu, W., Chari, A., & Richter, J. (2025). Author Correction: Mobilization strategies with and without plerixafor for autologous stem cell transplant in patients with multiple myeloma (Bone Marrow Transplantation, (2024), 59, 10, (1440-1448), 10.1038/s41409-024-02385-1). Bone Marrow Transplantation, 60(1), 115. https://doi.org/10.1038/s41409-024-02442-9

@article{77f7c7a01c584f6fa8fddba922391871,

title = "Author Correction: Mobilization strategies with and without plerixafor for autologous stem cell transplant in patients with multiple myeloma (Bone Marrow Transplantation, (2024), 59, 10, (1440-1448), 10.1038/s41409-024-02385-1)",

abstract = "Correction to: Bone Marrow Transplantationhttps://doi.org/10.1038/s41409-024-02385-1, published online 31 July 2024 Following the publication of this article it was noted that two authors were omitted: Erin Moshier1 and Weijia Fu11Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA. These authors have now been added to the author list. The Competing Interests statement has been updated as follows: DP: honoraria from Sanofi. TM: Employment at Karyopharm Therapeutics. AC: consulting for Sanofi. JR: consulting and honoraria from Sanofi. ZMA, SA, CF, JB, EM, WF and GM have no relevant conflicts of interest to disclose. The original article has been corrected.",

author = "Avigan, \{Zachary M.\} and Suzanne Arinsburg and Darren Pan and Tomer Mark and Christopher Fausel and Joseph Bubalo and Gary Milkovich and Erin Moshier and Weijia Fu and Ajai Chari and Joshua Richter",

note = "Publisher Copyright: {\textcopyright} The Author(s), under exclusive licence to Springer Nature Limited 2024.",

year = "2025",

month = jan,

doi = "10.1038/s41409-024-02442-9",

language = "English",

volume = "60",

pages = "115",

journal = "Bone Marrow Transplantation",

issn = "0268-3369",

publisher = "Springer Nature",

number = "1",

}

Avigan, ZM, Arinsburg, S, Pan, D, Mark, T, Fausel, C, Bubalo, J, Milkovich, G, Moshier, E, Fu, W, Chari, A & Richter, J 2025, 'Author Correction: Mobilization strategies with and without plerixafor for autologous stem cell transplant in patients with multiple myeloma (Bone Marrow Transplantation, (2024), 59, 10, (1440-1448), 10.1038/s41409-024-02385-1)', Bone Marrow Transplantation, vol. 60, no. 1, pp. 115. https://doi.org/10.1038/s41409-024-02442-9

Author Correction: Mobilization strategies with and without plerixafor for autologous stem cell transplant in patients with multiple myeloma (Bone Marrow Transplantation, (2024), 59, 10, (1440-1448), 10.1038/s41409-024-02385-1). / Avigan, Zachary M.; Arinsburg, Suzanne; Pan, Darren et al.
In: Bone Marrow Transplantation, Vol. 60, No. 1, 01.2025, p. 115.

Research output: Contribution to journal › Comment/debate

TY - JOUR

T1 - Author Correction

T2 - Mobilization strategies with and without plerixafor for autologous stem cell transplant in patients with multiple myeloma (Bone Marrow Transplantation, (2024), 59, 10, (1440-1448), 10.1038/s41409-024-02385-1)

AU - Avigan, Zachary M.

AU - Arinsburg, Suzanne

AU - Pan, Darren

AU - Mark, Tomer

AU - Fausel, Christopher

AU - Bubalo, Joseph

AU - Milkovich, Gary

AU - Moshier, Erin

AU - Fu, Weijia

AU - Chari, Ajai

AU - Richter, Joshua

PY - 2025/1

Y1 - 2025/1

N2 - Correction to: Bone Marrow Transplantationhttps://doi.org/10.1038/s41409-024-02385-1, published online 31 July 2024 Following the publication of this article it was noted that two authors were omitted: Erin Moshier1 and Weijia Fu11Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA. These authors have now been added to the author list. The Competing Interests statement has been updated as follows: DP: honoraria from Sanofi. TM: Employment at Karyopharm Therapeutics. AC: consulting for Sanofi. JR: consulting and honoraria from Sanofi. ZMA, SA, CF, JB, EM, WF and GM have no relevant conflicts of interest to disclose. The original article has been corrected.

AB - Correction to: Bone Marrow Transplantationhttps://doi.org/10.1038/s41409-024-02385-1, published online 31 July 2024 Following the publication of this article it was noted that two authors were omitted: Erin Moshier1 and Weijia Fu11Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA. These authors have now been added to the author list. The Competing Interests statement has been updated as follows: DP: honoraria from Sanofi. TM: Employment at Karyopharm Therapeutics. AC: consulting for Sanofi. JR: consulting and honoraria from Sanofi. ZMA, SA, CF, JB, EM, WF and GM have no relevant conflicts of interest to disclose. The original article has been corrected.

UR - https://www.scopus.com/pages/publications/85207283488

U2 - 10.1038/s41409-024-02442-9

DO - 10.1038/s41409-024-02442-9

M3 - Comment/debate

C2 - 39424960

AN - SCOPUS:85207283488

SN - 0268-3369

VL - 60

SP - 115

JO - Bone Marrow Transplantation

JF - Bone Marrow Transplantation

IS - 1

ER -

Avigan ZM, Arinsburg S, Pan D, Mark T, Fausel C, Bubalo J et al. Author Correction: Mobilization strategies with and without plerixafor for autologous stem cell transplant in patients with multiple myeloma (Bone Marrow Transplantation, (2024), 59, 10, (1440-1448), 10.1038/s41409-024-02385-1). Bone Marrow Transplantation. 2025 Jan;60(1):115. doi: 10.1038/s41409-024-02442-9